Michael Schmitt
Heidelberg University Hospital, Germany
- Publications: N/A
- Citations: N/A
- Keywords: Cell therapy, leukemia, antigens, CARTcells
Short Bio
- Michael Schmitt, MD, PhD is currently Siebeneicher-Endowment Professor of Cellular Immunotherapy and Head of the Good Manufacturing Practice (GMP) Facility at the University Clinic Heidelberg, Germany. He obtained his MD from the University of the Saarland, Homburg, Germany. At the Universities of Nagasaki and Mie, Japan he was introduced to the field of Tumor Immunology by Prof. H. Shiku. At the University of Ulm, Germany, Dr. Schmitt was trained by Prof. H. Döhner in Internal Medicine and Hematology/Oncology as well as in Stem Cell Transplantation by Prof. D. Bunjes. At the University of Rostock he served as Director of the Stem Cell Transplantation Program before he was appointed to his current position in Heidelberg. His main focus is on cell therapy with chimeric antigen receptor (CAR) T cells, T cell receptor (TCR) T cells, tolerance induction by cells, cancer vaccines, and stem cell mobilization. Dr. Schmitt obtained the Novartis Research Prize in 1999, the Felix Skubiszewski Medal of the Medical University of Lublin in 2005 as well as the Hans-Jochen Illiger Memorial Prize in 2008.
